Report Fraud About Us What We Do

Indivior Suboxone Settlement Rebates

Class Action Settlements

Indivior Suboxone Settlement – The $60 Million Settlement Rebates Arriving…

Suboxone Settlement Checks in the Mail

The opioid addiction medication Suboxone manufacturer Indivior and the Federal Trade Commission have negotiated a $60 million settlement. Class members have been reported to receive the rebate already.

The Allegation

Indivior Inc. and its subsidiary Reckitt Benckiser Group conspired to prohibit a lower-priced generic version of Suboxone from interfering with their significant pharmaceutical sales, as per the FTC.

Moreover, Indivior wrongly represented its Suboxone Film as being “less susceptible to accidental pediatric exposure than Suboxone Tablets,” which was brought up just before a generic version of Suboxone tablets hit the market. 

As a result, many consumers were apparently compelled to switch to Suboxone Film, which was the more expensive choice, due to this deceptive claim.

Indivior violated Section 5 of the FTC Act, according to the Suboxone lawsuit, by engaging in unlawful business practices that prevented competition.

The Indivior Settlement

All Suboxone Film prescriptions given in the United States between March 1, 2013, and February 28, 2019, were covered by the Suboxone settlement. 

The payout amount was determined by the total number of claims made and the length of time the consumer was given Suboxone film.

To get a refund check, consumers were asked to register a claim no later than December 1, 2020, to follow the terms of the FTC settlement.

No proof of purchase was necessary at the time. However, consumers were suggested to still keep any supporting documentation just in case the settlement administrator encounters any issues later on.

Editor’s Note on Indivior Suboxone Settlement:

This article is published to inform you of the latest settlement for a lawsuit filed against Suboxone manufacturer Indivior Inc. and its subsidiary Reckitt Benckiser Group. 

Case Name & No.: FTC v. Indivior, Case No. 1:20-cv-00036-JPJ-PMS, and FTC v. Reckitt Benckiser Group PLC, Case No. 1:19-cv-00028, both in the U.S. District Court for the Western District of Virginia, Abingdon

Products/Services: Suboxone medication

Allegations: Indivior Inc. and Reckitt Benckiser Group violated Section 5 of the FTC Act by engaging in unlawful business practices that prevented competition

Status: Settled 

Do you take opioid addiction medication Suboxone? Were you able to file a claim before December 1, 2020? Have you received your payment?

If something doesn’t feel right, do not hesitate to message us about it by clicking the ‘Contact Us’ button below. We would love to hear from you. 

Contact Us

You can also reach out to us on Twitter or Facebook or via email at Outreach@ConsiderTheConsumer.com. Also, directly on our website! We look forward to hearing from you.

Suggested Article: Latanya Simmons Apple Powerbeats 2 Settlement Checks

Interested in posts like these? Stay up to date with our newsletter!

No thoughts on “Indivior Suboxone Settlement – The $60 Million Settlement Rebates Arriving…” yet. Be the first to speak your mind!

Leave a Reply